Ion Beam Applications SA
Sumit Sharma is an accomplished professional with extensive experience in the healthcare and nuclear medicine sectors. Currently serving as the General Manager for South Asia, Australia, and New Zealand at Curium Pharma since January 2023, Sumit has effectively led the Nuclear Medicine business in South Asia as the Sales & Marketing Manager at IBA since June 2010. Prior roles include Divisional Manager for South Asia at Covidien, where Sumit led initiatives in Interventional Oncology. Additional experience encompasses managerial positions at DCA, Bausch & Lomb, GE Healthcare, Amersham Health, and Nycomed India, demonstrating a strong background in marketing and business management across various regions in India. Sumit holds an MBA in Marketing from the Institute of Management Technology, Ghaziabad.
This person is not in any offices
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.